Human PRKD2 adenoviral particles

The PRKD2 (protein kinase D2) gene encodes a serine/threonine kinase that belongs to the protein kinase D (PKD) family, which plays a key role in a variety of cellular processes including signal transduction, cell proliferation, apoptosis, and membrane trafficking. PRKD2 is activated by diacylglycerol (DAG) and phosphorylation and is typically downstream of G protein-coupled receptors (GPCRs) or receptor tyrosine kinases. It regulates key pathways such as NF-κB, MAPK, and Golgi organization, affecting cancer progression, immune responses, and cardiovascular function. Studies have shown that PRKD2 has dual roles as an oncogene and tumor suppressor, depending on the cellular context, making it a popular target for biomedical research. Human PRKD2 adenoviral particles are replication-defective viral vectors designed to efficiently deliver the PRKD2 gene to mammalian cells. These particles exploit the natural tropism of adenoviruses to infect a variety of cell types, including dividing and non-dividing cells, making them ideal for in vitro and in vivo studies. Applications include elucidating the mechanistic role of PRKD2 in disease, screening drug candidates, and gene therapy development. Safety-enhanced designs, such as E1/E3 deletions, minimize cytotoxicity while maximizing experimental reproducibility.